Gainesville, FL12 Active Studies

Parkinsons Disease Clinical Trials in Gainesville, FL

Find 12 actively recruiting parkinsons disease clinical trials in Gainesville, FL. Connect with local research sites and explore new treatment options.

12
Active Trials
5
Sponsors
4,312
Enrolling

Recruiting Parkinsons Disease Studies in Gainesville

About Parkinsons Disease Clinical Trials in Gainesville

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 12 parkinsons disease clinical trials recruiting participants in Gainesville, FL. These studies are seeking a combined 4,312 participants. Research is being sponsored by Michael J. Fox Foundation for Parkinson's Research, Boston Scientific Corporation, VA Office of Research and Development and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in Gainesville — FAQ

Are there parkinsons disease clinical trials in Gainesville?

Yes, there are 12 parkinsons disease clinical trials currently recruiting in Gainesville, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Gainesville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Gainesville research site will contact you about next steps.

Are clinical trials in Gainesville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Gainesville studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 12 active trials in Gainesville are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated July 18, 2026 from ClinicalTrials.gov